Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.

Although it is seeing a downturn in sales and profits, German biotech BioNTech (Nasdaq: BNTX) is continuing to acquire assets ...

The CDC urges both an updated COVID-19 shot and yearly flu vaccine for everyone ages 6 months and older ... s are tailored to ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

November 13th has seen a myriad of significant events throughout history, impacting various spheres such as politics, science ...

At the height of the pandemic, the race was on for a COVID-19 vaccine that could save lives and hasten a ... In November 2020 ...

The data from the CDC's National Immunization Survey estimates that 37.6% of Americans ages 65 and older had gotten a shot of ...

In its recent third-quarter 2024 earnings report, Novavax highlighted significant advancements in its vaccine portfolio, including the removal of a clinical hold by the U.S. FDA on its ...

If you haven’t gotten your flu or COVID-19 shot yet this season, Wisconsin health officials are urging people to do so ahead ...

Geovax Labs, Inc. ( (GOVX) ) has released its Q3 earnings. Here is a breakdown of the information Geovax Labs, Inc. presented to its investors.